Wuhan Healthgen Biotechnology Corp

NEW
SHSE:688765 (China)   Ordinary Shares - Class A
Â¥ 38.5 -0.50 (-1.28%) Aug 28
At Loss
P/B:
4.80
Market Cap:
Â¥ 13.76B ($ 2.05B)
Enterprise V:
Â¥ 13.68B ($ 2.03B)
Volume:
4.60M
Avg Vol (2M):
4.28M
Trade In:
Volume:
4.60M
At Loss

Wuhan Healthgen Biotechnology Corp (SHSE:688765) Dividend

Wuhan Healthgen Biotechnology Corp (SHSE:688765) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -10.1%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: SHSE:688765 Dividend

Does Wuhan Healthgen Biotechnology Corp (SHSE:688765) pay a dividend?

Wuhan Healthgen Biotechnology Corp (SHSE:688765) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Wuhan Healthgen Biotechnology Corp pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Wuhan Healthgen Biotechnology Corp has returned capital to shareholders via buybacks at a rate of -10.1% over the past 3 years.

What are dividend-paying alternatives to Wuhan Healthgen Biotechnology Corp?

For dividend-paying alternatives in Wuhan Healthgen Biotechnology Corp's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.